摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6-dichloro-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)benzimidazole | 137016-56-9

中文名称
——
中文别名
——
英文名称
5,6-dichloro-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)benzimidazole
英文别名
[(2R,3R,4R,5R)-3,4-dibenzoyloxy-5-(5,6-dichlorobenzimidazol-1-yl)oxolan-2-yl]methyl benzoate
5,6-dichloro-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)benzimidazole化学式
CAS
137016-56-9
化学式
C33H24Cl2N2O7
mdl
——
分子量
631.469
InChiKey
YAUHECMXGBGASJ-SKKKGAJSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    768.8±70.0 °C(Predicted)
  • 密度:
    1.42±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    6.55
  • 重原子数:
    44.0
  • 可旋转键数:
    8.0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    105.95
  • 氢给体数:
    0.0
  • 氢受体数:
    9.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    5,6-二氯苯并咪唑2'→5'-和3'→5'-核苷酸二聚体和三聚体的合成及性质
    摘要:
    通过融合法合成的5,6-二氯-1-β-D-呋喃呋喃糖基苯并咪唑(2)用于合成2'---- 5'-和3'---- 5'-连接的二-和三聚体寡核苷酸。所用的保护基团是对HO-5′为对甲氧基三苯甲基,对HO-2′,3′为叔丁基二甲基甲硅烷基,对磷酸酯基为2,5-二氯苯基和2-(4-硝基苯基)乙基。通过磷酸三酯方法建立核苷酸间键,以得到完全保护的2'---- 5'二聚体(15、17和18)和三聚体(27和28),以及3'---- 5二聚体(22和23)和三聚体(31和32)。脱保护涉及一系列步骤,以高收率得到相应的游离寡核苷酸21、26、30和33,其被分离为三乙铵盐。
    DOI:
    10.1016/0008-6215(92)84178-u
  • 作为产物:
    描述:
    1-乙酰氧基-2,3,5-三苯甲酰氧基-1-beta-D-呋喃核糖5-甲基苯并咪唑对甲苯磺酸 作用下, 170.0~180.0 ℃ 、2.67 kPa 条件下, 反应 1.0h, 以51%的产率得到5,6-dichloro-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)benzimidazole
    参考文献:
    名称:
    5,6-二氯苯并咪唑2'→5'-和3'→5'-核苷酸二聚体和三聚体的合成及性质
    摘要:
    通过融合法合成的5,6-二氯-1-β-D-呋喃呋喃糖基苯并咪唑(2)用于合成2'---- 5'-和3'---- 5'-连接的二-和三聚体寡核苷酸。所用的保护基团是对HO-5′为对甲氧基三苯甲基,对HO-2′,3′为叔丁基二甲基甲硅烷基,对磷酸酯基为2,5-二氯苯基和2-(4-硝基苯基)乙基。通过磷酸三酯方法建立核苷酸间键,以得到完全保护的2'---- 5'二聚体(15、17和18)和三聚体(27和28),以及3'---- 5二聚体(22和23)和三聚体(31和32)。脱保护涉及一系列步骤,以高收率得到相应的游离寡核苷酸21、26、30和33,其被分离为三乙铵盐。
    DOI:
    10.1016/0008-6215(92)84178-u
点击查看最新优质反应信息

文献信息

  • High-Throughput Five Minute Microwave Accelerated Glycosylation Approach to the Synthesis of Nucleoside Libraries
    作者:Brett C. Bookser、Nicholas B. Raffaele
    DOI:10.1021/jo061885l
    日期:2007.1.1
    [GRAPHICS]The Vorbruggen glycosylation reaction was adapted into a one-step 5 min/130 degrees C microwave assisted reaction. Triethanolamine in acetontrile containing 2% water was determined to be optimal for the neutralization of trimethylsilyl triflate allowing for direct MPLC purification of the reaction mixture. When coupled with a NH3/methanol deprotection reaction, a high-throughput method of nucleoside library synthesis was enabled. The method was demonstrated by examining the ribosylation of 48 nitrogen containing heteroaromatic bases that included 25 purines, four pyrazolopyrimidines, two 8-azapurines, one 2-azapurine, two imidazopyridines, two benzimidazoles, three imidazoles, three 1,2,4-triazoles, two pyrimidines, two 3-deazapyrimidines, one quinazolinedione, and one alloxazine. Of these, 32 yielded single regioisomer products, and six resulted in separable mixtures. Seven examples provided inseparable regioisomer mixtures of -two to three compounds (16 nucleosides), and three examples failed to yield isolable products. For the 45 single isomers isolated, the average two-step overall yield +/- SD was 26 +/- 16%, and the average purity +/- SD was 95 +/- 6%. A total of 58 different nucleosides were prepared of which 15 had not previously been accessed directly from glycosylation/deprotection of a readily available base.
查看更多

同类化合物

直链-苯并腺苷二磷酸酯 [(2R,3R,4R,5R)-2-(5,6-二氯苯并咪唑-1-基)-4-羟基-5-(羟基甲基)四氢呋喃-3-基]磷酸二氢酯 BENZIMIDAVIR苯并咪唑核苷 8-氨基-3-beta-D-呋喃核糖基咪唑并[4,5-g]喹唑啉 5,6-二甲基-1-(5-O-膦酰-alpha-D-呋喃核糖基)-1H-苯并咪唑 5,6-二氯-1-β-D-呋喃核糖基苯并咪唑 2-氯-5,6-二甲基-1-beta-D-呋喃核糖基苯并咪唑 2,5-哌嗪二酮,3-甲基-6-(2-甲基丙基)-,反-(9CI) 1,3-二去氮杂腺苷 (2S,3R,4S,5R)-2-(5,6-二甲基苯并咪唑-1-基)-5-(羟基甲基)四氢呋喃-3,4-二醇 2-amino-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1H-benzimidazole 2,5,6-trichloro-1-(2-O-acetyl-3,5-di-O-benzoyl-β-L-xylofuranosyl)benzimidazole 1-(2',3',5'-tri-O-acetyl-α-D-lyxofuranosyl)-2,5,6-trichlorobenzimidazole Acetic acid (2R,3R,4R,5S)-4-acetoxy-5-acetoxymethyl-2-(2-bromo-5,6-dichloro-benzoimidazol-1-yl)-tetrahydro-furan-3-yl ester α-Ribazol-3'(2')-phosphorsaeureester 1-(2,3,5-tri-O-acetyl-α-L-lyxofuranosyl)-2,5,6-trichlorobenzimidazole 2'-Benzoyl-1-β-D-ribofuranosylbenzimidazol (1Ξ)-1-(5,6-dimethyl-benzimidazol-1-yl)-1,4-anhydro-L-arabitol 1-(6-acetylamino-4-bromo-imidazo[4,5-c]pyridin-1-yl)-tri-O-benzoyl-α-D-1-deoxy-ribofuranose 2-azido-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1H-benzimidazole 3'-Benzoyl-1-β-D-ribofuranosylbenzimidazol tri-O-acetyl-1-(8-methylsulfanyl-imidazo[4,5-g]quinazolin-1-yl)-β-D-1-deoxy-ribofuranose 3-aminopropyl-2'-(α-ribazolyl)-diphosphate 1-(6-acetylamino-4-bromo-imidazo[4,5-c]pyridin-1-yl)-tri-O-benzoyl-β-D-1-deoxy-ribofuranose 1-(6-amino-4-methylsulfanyl-imidazo[4,5-c]pyridin-1-yl)-β-D-1-deoxy-ribofuranose 2-iodo-5,6-dichloro-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)benzimidazole Formamidoribosid 2-bromo-5,6-dichloro-1-(2,3,5-tri-O-acetyl-β-L-ribofuranosyl)benzimidazole Formamidoribosid 5,6-dichloro-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)benzimidazole-2-thione 1-(tri-O-benzoyl-β-D-ribofuranosyl)-1,3-dihydro-benzoimidazole-2-thione 5,6-dichloro-1-β-D-ribofuranosylbenzimidazolyl-(2'->5')-5,6-dichloro-1-β-D-ribofuranosylbenzimidazolyl-(2'->5')-5,6-dichloro-1-β-D-ribofuranosylbenzimidazole bis(triethylammonium) salt 5,6-dichloro-1-β-D-ribofuranosylbenzimidazolyl-(2'->5')-5,6-dichloro-1-β-D-ribofuranosylbenzimidazole triethylammonium salt tri-O-benzoyl-1-(2-methylsulfanyl-benzoimidazol-1-yl)-β-D-1-deoxy-ribofuranose 2-Allylthio-1-(β-D-ribofuranosyl)benzimidazol 1-benzoimidazol-1-yl-tri-O-benzoyl-α-D-1-deoxy-ribofuranose Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-acetoxymethyl-2-(4,6-dichloro-2-thioxo-2,3-dihydro-benzoimidazol-1-yl)-tetrahydro-furan-3-yl ester 2-Chloro-6-bromo-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)benzimidazole 6-amino-1-(tri-O-benzoyl-β-D-ribofuranosyl)-1,5-dihydro-imidazo[4,5-c]pyridine-4-thione Bis-5',5'- 1-(6-amino-4-bromo-imidazo[4,5-c]pyridin-1-yl)-tri-O-benzoyl-β-D-1-deoxy-ribofuranose (2R,3R,4R,5R)-2-(acetoxymethyl)-5-(5,6-dimethoxy-1H-benzo[d]imidazol-1-yl)tetrahydrofuran-3,4-diyl diacetate 2-azido-4,6-dichloro-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)benzimidazole 2-bromo-4,6-dichloro-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)benzimidazole 2,4,6-trichloro-1-(β-D-ribofuranosyl)benzimidazole 1-(2,3,5-Tri-O-acetyl-α-D-ribofuranosyl)-5,6-dimethyl-benzimidazol od. α-Ribazol-triacetat 2,4,6-trichloro-1-(2,3,5-tri-O-acetyl-α-D-ribofuranosyl)benzimidazole 2-bromo-6-trifluoromethyl-1-(5-deoxy-beta-D-ribofuranosyl)-1H-benzimidazole